(PAYX) Paychex - Ratings and Ratios
Payroll, HR Solutions, Benefits, Insurance, Compliance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.79% |
| Yield on Cost 5y | 5.28% |
| Yield CAGR 5y | 12.87% |
| Payout Consistency | 98.2% |
| Payout Ratio | 84.4% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 21.5% |
| Value at Risk 5%th | 33.6% |
| Relative Tail Risk | -5.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.86 |
| Alpha | -29.93 |
| CAGR/Max DD | 0.04 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.555 |
| Beta | 0.551 |
| Beta Downside | 0.503 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.94% |
| Mean DD | 7.11% |
| Median DD | 5.37% |
Description: PAYX Paychex December 04, 2025
Paychex Inc. (NASDAQ: PAYX) delivers a suite of human capital management (HCM) solutions-including payroll processing, tax administration, benefits administration, talent acquisition, and risk-management services-to small- and medium-sized enterprises across the United States, Europe, and India. Its offerings span the full employee lifecycle, from recruiting and onboarding through retirement, and are sold primarily via a direct sales force.
Key recent metrics show FY 2023 revenue of roughly $5.1 billion, up about 8 % year-over-year, with adjusted earnings per share of $6.70 and an operating margin near 20 %. The business benefits from two macro-drivers: (1) continued hiring growth and wage inflation in the U.S. SMB segment, which raises payroll volume and compliance complexity, and (2) accelerating adoption of cloud-based HCM platforms that boost demand for integrated, subscription-style services. Paychex’s market share in the U.S. payroll processing market remains around 20 %, and its churn rate for core payroll clients stays below 3 %-a sign of sticky revenue.
For a deeper quantitative comparison of PAYX’s valuation metrics, you might explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (1.60b TTM) > 0 and > 6% of Revenue (6% = 362.0m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -2.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 30.96% (prev 39.12%; Δ -8.15pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 2.28b > Net Income 1.60b (YES >=105%, WARN >=100%) |
| Net Debt (3.50b) to EBITDA (2.66b) ratio: 1.31 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (361.1m) change vs 12m ago -0.19% (target <= -2.0% for YES) |
| Gross Margin 73.36% (prev 71.80%; Δ 1.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 44.57% (prev 50.88%; Δ -6.30pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 10.38 (EBITDA TTM 2.66b / Interest Expense TTM 223.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.44
| (A) 0.11 = (Total Current Assets 8.91b - Total Current Liabilities 7.04b) / Total Assets 16.52b |
| (B) 0.12 = Retained Earnings (Balance) 1.95b / Total Assets 16.52b |
| (C) 0.17 = EBIT TTM 2.32b / Avg Total Assets 13.54b |
| (D) 0.15 = Book Value of Equity 1.94b / Total Liabilities 12.64b |
| Total Rating: 2.44 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 88.05
| 1. Piotroski 6.50pt |
| 2. FCF Yield 4.85% |
| 3. FCF Margin 34.10% |
| 4. Debt/Equity 1.30 |
| 5. Debt/Ebitda 1.31 |
| 6. ROIC - WACC (= 14.89)% |
| 7. RoE 39.66% |
| 8. Rev. Trend 82.03% |
| 9. EPS Trend 49.68% |
What is the price of PAYX shares?
Over the past week, the price has changed by -1.91%, over one month by -1.09%, over three months by -9.71% and over the past year by -15.69%.
Is PAYX a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 13
- Sell: 3
- Strong Sell: 1
What are the forecasts/targets for the PAYX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 122.1 | 9.8% |
| Analysts Target Price | 122.1 | 9.8% |
| ValueRay Target Price | 107 | -3.8% |
PAYX Fundamental Data Overview January 05, 2026
P/E Trailing = 24.5701
P/E Forward = 19.8413
P/S = 6.4608
P/B = 10.0471
P/EG = 2.0677
Beta = 0.898
Revenue TTM = 6.03b USD
EBIT TTM = 2.32b USD
EBITDA TTM = 2.66b USD
Long Term Debt = 4.55b USD (from longTermDebt, last quarter)
Short Term Debt = 418.1m USD (from shortTermDebt, last quarter)
Debt = 5.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.50b USD (from netDebt column, last quarter)
Enterprise Value = 42.45b USD (38.98b + Debt 5.04b - CCE 1.57b)
Interest Coverage Ratio = 10.38 (Ebit TTM 2.32b / Interest Expense TTM 223.0m)
FCF Yield = 4.85% (FCF TTM 2.06b / Enterprise Value 42.45b)
FCF Margin = 34.10% (FCF TTM 2.06b / Revenue TTM 6.03b)
Net Margin = 26.45% (Net Income TTM 1.60b / Revenue TTM 6.03b)
Gross Margin = 73.36% ((Revenue TTM 6.03b - Cost of Revenue TTM 1.61b) / Revenue TTM)
Gross Margin QoQ = 73.54% (prev 73.13%)
Tobins Q-Ratio = 2.57 (Enterprise Value 42.45b / Total Assets 16.52b)
Interest Expense / Debt = 1.36% (Interest Expense 68.5m / Debt 5.04b)
Taxrate = 23.99% (124.8m / 520.2m)
NOPAT = 1.76b (EBIT 2.32b * (1 - 23.99%))
Current Ratio = 1.27 (Total Current Assets 8.91b / Total Current Liabilities 7.04b)
Debt / Equity = 1.30 (Debt 5.04b / totalStockholderEquity, last quarter 3.88b)
Debt / EBITDA = 1.31 (Net Debt 3.50b / EBITDA 2.66b)
Debt / FCF = 1.70 (Net Debt 3.50b / FCF TTM 2.06b)
Total Stockholder Equity = 4.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.66% (Net Income 1.60b / Total Assets 16.52b)
RoE = 39.66% (Net Income TTM 1.60b / Total Stockholder Equity 4.02b)
RoCE = 27.00% (EBIT 2.32b / Capital Employed (Equity 4.02b + L.T.Debt 4.55b))
RoIC = 22.13% (NOPAT 1.76b / Invested Capital 7.95b)
WACC = 7.24% (E(38.98b)/V(44.02b) * Re(8.04%) + D(5.04b)/V(44.02b) * Rd(1.36%) * (1-Tc(0.24)))
Discount Rate = 8.04% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.14%
[DCF Debug] Terminal Value 79.69% ; FCFE base≈1.86b ; Y1≈2.06b ; Y5≈2.67b
Fair Price DCF = 129.2 (DCF Value 46.38b / Shares Outstanding 359.0m; 5y FCF grow 12.21% → 3.0% )
EPS Correlation: 49.68 | EPS CAGR: -1.18% | SUE: -2.90 | # QB: 0
Revenue Correlation: 82.03 | Revenue CAGR: 5.46% | SUE: 0.00 | # QB: 0
EPS next Quarter (2026-02-28): EPS=1.67 | Chg30d=+0.009 | Revisions Net=+2 | Analysts=16
EPS current Year (2026-05-31): EPS=5.49 | Chg30d=+0.022 | Revisions Net=+13 | Growth EPS=+10.2% | Growth Revenue=+16.7%
EPS next Year (2027-05-31): EPS=5.91 | Chg30d=+0.016 | Revisions Net=+1 | Growth EPS=+7.7% | Growth Revenue=+5.9%
Additional Sources for PAYX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle